[1]
|
Nikoletopoulou, V., Markaki, M., Palikaras, K. and Tavernarakis, N. (2013) Crosstalk between Apoptosis, Necrosis and Autophagy. Biochimica et Biophysica Acta, 1833, 3448-3459. https://doi.org/10.1016/j.bbamcr.2013.06.001
|
[2]
|
Galluzzi, L., Maiuri, M.C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L., et al. (2007) Cell Death Modalities: Classification and Pathophysiological Implications. Cell Death & Differentiation, 14, 1237-1243. https://doi.org/10.1038/sj.cdd.4402148
|
[3]
|
Baines, C.P., Kaiser, R., Purcell, N.H., Blair, N.S., Osinska, H., Hambleton, M.A., et al. (2005) Loss of Cyclophilin D Reveals a Critical Role for Mitochondrial Permeability Transition in Cell Death. Nature, 434, 658-662.
https://doi.org/10.1038/nature03434
|
[4]
|
Nakayama, H., Chen, X., Baines, C.P., Klevitsky, R., Zhang, X., Zhang, H., et al. (2007) Ca2+- and Mitochondrial-Dependent Cardiomyocyte Necrosis as a Primary Mediator of Heart Failure. The Journal of Clinical Investigation, 117, 2431-2444.
https://doi.org/10.1172/JCI31060
|
[5]
|
Kung, G., Konstantinidis, K. and Kitsis, R.N. (2011) Programmed Necrosis, Not Apoptosis in the Heart. Circulation Research, 108, 1017-1036.
https://doi.org/10.1161/CIRCRESAHA.110.225730
|
[6]
|
Adams, J.M. (2003) Ways of Dying: Multiple Pathways to Apoptosis. Genes & Development, 17, 2481-2495. https://doi.org/10.1101/gad.1126903
|
[7]
|
Kroemer, G., Galluzzi, L. and Brenner, C. (2007) Mitochondrial Membrane Permeabilization in Cell Death. Physiological Reviews, 87, 99-163.
https://doi.org/10.1152/physrev.00013.2006
|
[8]
|
Los, M., Mozoluk, M., Ferrari, D., Stepczynska, A., Stroh, C., Renz, A., et al. (2002) Activation and Caspase-Mediated Inhibition of PARP: A Molecular Switch between Fibroblast Necrosis and Apoptosis in Death Receptor Signaling. Molecular Biology of the Cell, 13, 978-988. https://doi.org/10.1091/mbc.01-05-0272
|
[9]
|
Kajstura, J., Cheng, W., Reiss, K., Clark, W.A., Sonnenblick, E.H., Krajewski, S., et al. (1996) Apoptotic and Necrotic Myocyte Cell Deaths Are Independent Contributing Variables of Infarct Size in Rats. Laboratory Investigation, 74, 86-107.
|
[10]
|
Yaoita, H., Ogawa, K., Maehara, K. and Maruyama, Y. (1998) Attenuation of Ischemia/Reperfusion Injury in Rats by a Caspase Inhibitor. Circulation, 97, 276-281.
https://doi.org/10.1161/01.CIR.97.3.276
|
[11]
|
Zingarelli, B., Salzman, A.L. and Szabo, C. (1998) Genetic Disruption of Poly (ADP-Ribose) Synthetase Inhibits the Expression of P-Selectin and Intercellular Adhesion Molecule-1 in Myocardial Ischemia/Reperfusion Injury. Circulation Research, 83, 85-94. https://doi.org/10.1161/01.RES.83.1.85
|
[12]
|
Levine, B. and Kroemer, G. (2008) Autophagy in the Pathogenesis of Disease. Cell, 132, 27-42. https://doi.org/10.1016/j.cell.2007.12.018
|
[13]
|
Mizushima, N., Levine, B., Cuervo, A.M. and Klionsky, D.J. (2008) Autophagy Fights Disease through Cellular Self-Digestion. Nature, 451, 1069-1075.
https://doi.org/10.1038/nature06639
|
[14]
|
Mizushima, N. and Levine, B. (2010) Autophagy in Mammalian Development and Differentiation. Nature Cell Biology, 12, 823-830.
https://doi.org/10.1038/ncb0910-823
|
[15]
|
Murry, C.E., Jennings, R.B. and Reimer, K.A. (1994) What Is Ischemic Preconditioning? In: Przyklenk, K., Kloner, R.A. and Yellon, D.M., Eds., Ischemic Preconditioning: The Concept of Endogenous Cardioprotection, Kluwer Academic Publishers, Boston, 3-17.
|
[16]
|
Downey, J.M. and Cohen, M.V. (1997) Preconditioning: What It Is and How It Works. Dialogues in Cardiovascular Medicine, 2, 179-196.
|
[17]
|
Jenkins, D.P., Baxter, G.F. and Yellon, D.M. (1995) The Pathophysiology of Ischaemic Preconditioning. Pharmacological Research, 31, 219-224.
https://doi.org/10.1016/1043-6618(95)80022-0
|
[18]
|
Das, D.K., Engelman, R.M. and Kimura, Y. (1993) Molecular Adaptation of Cellular Defences during Preconditioning of the Heart by Repeated Ischaemia. Cardiovascular Research, 27, 578-584. https://doi.org/10.1093/cvr/27.4.578
|
[19]
|
Gross, G.J. and Peart, J.N. (2003) KATP Channels and Myocardial Preconditioning: An Update. American Journal of Physiology-Heart and Circulatory Physiology, 285, H921-H930. https://doi.org/10.1152/ajpheart.00421.2003
|
[20]
|
Peart, J.N., Gross, E.R. and Gross, G.J. (2005) Opioid-Induced Preconditioning: Recent Advances and Future Perspectives. Vascular Pharmacology, 42, 211-218.
https://doi.org/10.1016/j.vph.2005.02.003
|
[21]
|
Sun, J.-Z., Tang, X.-L., Knowlton, A.A., Park, S.-W., Qiu, Y. and Bolli, R. (1995) Late Preconditioning against Myocardial Stunning. An Endogenous Protective Mechanism That Confers Resistance to Postischemic Dysfunction 24 h after Brief Ischemia in Conscious Pigs. The Journal of Clinical Investigation, 95, 388-403.
https://doi.org/10.1172/JCI117667
|
[22]
|
Yellon, D.M. and Baxter, G.F. (1995) A “Second Window of Protection” or Delayed Preconditioning Phenomenon: Future Horizons for Myocardial Protection? Journal of Molecular and Cellular Cardiology, 27, 1023-1034.
https://doi.org/10.1016/0022-2828(95)90071-3
|
[23]
|
Gottlieb, R.A., Gruol, D.E., Zhu, J.Y. and Engler, R.L. (1996) Preconditioning in Rabbit Cardiomyocytes: Role of pH, Vacuolar Proton ATPase, and Apoptosis. The Journal of Clinical Investigation, 97, 2391-2398. https://doi.org/10.1172/JCI118683
|
[24]
|
Piot, C.A., Padmanaban, D., Ursell, P.C., Sievers, R.E. and Wolfe, C. (1997) Ischemic Preconditioning Decreases Apoptosis in Rat Hearts in Vivo. Circulation, 96, 1598-1604.
https://doi.org/10.1161/01.CIR.96.5.1598
|
[25]
|
Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M. and Altman, D.G. (2010) Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLOS Biology, 8, e1000412.
https://doi.org/10.1371/journal.pbio.1000412
|
[26]
|
Duriez, P.J. and Shah, G.M. (1997) Cleavage of Poly(ADP-ribose) Polymerase: A Sensitive Parameter to Study Cell Death. Biochemistry and Cell Biology, 75, 337-349.
https://doi.org/10.1139/o97-043
|
[27]
|
Kingma, J.G. (1999) Cardiac Adaptation to Ischemia-Reperfusion Injury. Annals of the New York Academy of Sciences, 874, 83-99.
https://doi.org/10.1111/j.1749-6632.1999.tb09227.x
|
[28]
|
Kingma, J.G. (2021) Ischemic Conditioning-Mediated Myocardial Protection in Relation to Duration of Coronary Occlusion. World Journal of Cardiovascular Diseases, 11, 210-222. https://doi.org/10.4236/wjcd.2021.113021
|
[29]
|
McCully, J.D., Wakiyama, H., Hsieh, Y.J., Jones, M. and Levitsky, S. (2004) Differential Contribution of Necrosis and Apoptosis in Myocardial Ischemia-Reperfusion Injury. American Journal of Physiology-Heart and Circulatory Physiology, 286, H1923-H1935.
https://doi.org/10.1152/ajpheart.00935.2003
|
[30]
|
Skulachev, V.P. (2006) Bioenergetic Aspects of Apoptosis, Necrosis and Mitoptosis. Apoptosis, 11, 473-485. https://doi.org/10.1007/s10495-006-5881-9
|
[31]
|
Reimer, K.A., Murry, C.E., Yamasawa, I. and Hill, M.L. (1986) Four Brief Periods of Myocardial Ischemia Cause No Cumulative ATP Loss or Necrosis. American Journal of Physiology-Heart and Circulatory Physiology, 251, H1306-H1315.
https://doi.org/10.1152/ajpheart.1986.251.6.H1306
|
[32]
|
Murry, C.E., Richard, V.J., Reimer, K.A. and Jennings, R.B. (1990) Ischemic Preconditioning Slows Energy Metabolism and Delays Ultrastructural Damage during a Sustained Ischemic Episode. Circulation Research, 66, 913-931.
https://doi.org/10.1161/01.RES.66.4.913
|
[33]
|
Buja, L.M. and Vela, D. (2008) Cardiomyocyte Death and Renewal in the Normal and Diseased Heart. Cardiovascular Pathology, 17, 349-374.
https://doi.org/10.1016/j.carpath.2008.02.004
|
[34]
|
Buja, L.M. (1998) Modulation of the Myocardial Response to Ischemia. Laboratory Investigation, 78, 1345-1373.
|
[35]
|
Scarabelli, T.M., Stephanou, A., Pasini, E., Comini, L., Raddino, R., Knight, R.A., et al. (2002) Different Signaling Pathways Induce Apoptosis in Endothelial Cells and Cardiac Myocytes during Ischemia/Reperfusion Injury. Circulation Research, 90, 745-748. https://doi.org/10.1161/01.RES.0000015224.07870.9A
|
[36]
|
Szabo, C. (2005) Cardioprotective Effects of Poly(ADP-ribose) Polymerase Inhibition. Pharmacological Research, 52, 34-43.
https://doi.org/10.1016/j.phrs.2005.02.017
|
[37]
|
Kim, M.Y., Zhang, T. and Kraus, W.L. (2005) Poly(ADP-ribosyl)ation by PARP-1: “PAR-Laying” NAD+ into a Nuclear Signal. Genes & Development, 19, 1951-1967.
https://doi.org/10.1101/gad.1331805
|
[38]
|
Sodhi, R.K., Singh, M., Singh, N. and Jaggi, A.S. (2009) Protective Effects of Caspase-9 and Poly(ADP-ribose) Polymerase Inhibitors on Ischemia-Reperfusion-Induced Myocardial Injury. Archives of Pharmacal Research, 32, 1037-1043.
https://doi.org/10.1007/s12272-009-1709-9
|
[39]
|
Piot, C.A., Martini, J.F., Bui, S.K. and Wolfe, C.L. (1999) Ischemic Preconditioning Attenuates Ischemia/Reperfusion-Induced Activation of Caspases and Subsequent Cleavage of Poly(ADP-ribose) Polymerase in Rat Hearts in Vivo. Cardiovascular Research, 44, 536-542. https://doi.org/10.1016/S0008-6363(99)00227-8
|
[40]
|
Ohno, M., Takemura, G., Ohno, A., Misao, J., Hayakawa, Y., Minatoguchi, S., et al. (1998) “Apoptotic” Myocytes in Infarct Area in Rabbit Hearts May Be Oncotic Myocytes with DNA Fragmentation. Analysis by Immunogold Electron Microscopy Combined with in Situ Nick End-Labelling. Circulation, 98, 1422-1430.
https://doi.org/10.1161/01.CIR.98.14.1422
|
[41]
|
Gottlieb, R.A., Burleson, K.O., Kloner, R.A., Babior, B.M. and Engler, R.L. (1994) Reperfusion Injury Induces Apoptosis in Rabbit Cardiomyocytes. The Journal of Clinical Investigation, 94, 1621-1628. https://doi.org/10.1172/JCI117504
|
[42]
|
Fliss, H. and Gattinger, D. (1996) Apoptosis in Ischemic and Reperfused Rat Myocardium. Circulation Research, 79, 949-956.
https://doi.org/10.1161/01.RES.79.5.949
|
[43]
|
Von Harsdorf, R., Li, P.F. and Dietz, R. (1999) Signaling Pathways in Reactive Oxygen Species-Induced Cardiomyocyte Apoptosis. Circulation, 99, 2934-2941.
https://doi.org/10.1161/01.CIR.99.22.2934
|
[44]
|
Bolli, R., Zughaib, M., Li, X.-Y., Tang, X.-L., Sun, J.-Z., Triana, J.F., et al. (1995) Recurrent Ischemia in the Canine Heart Causes Recurrent Bursts of Free Radical Production That Have a Cumulative Effect on Contractile Function. A Pathophysiological Basis for Chronic Myocardial “Stunning”. The Journal of Clinical Investigation, 96, 1066-1084. https://doi.org/10.1172/JCI118093
|
[45]
|
Zingarelli, B., Cuzzocrea, S., Zsengeller, Z., Salzman, A.L. and Szabo, C. (1997) Protection against Myocardial Ischemia and Reperfusion Injury by 3-Aminobenzamide, an Inhibitor of Poly(ADP ribose) Synthetase. Cardiovascular Research, 36, 205-215.
https://doi.org/10.1016/S0008-6363(97)00137-5
|
[46]
|
Cuzzocrea, S., Zingarelli, B., O’Connor, M., Salzman, A.L., Caputi, A.P. and Szabo, C. (1997) Role of Peroxynitrite and Activation of Poly(ADP-ribose) Synthase in the Vascular Failure Induced by Zymosan-Activated Plasma. British Journal of Pharmacology, 122, 493-503. https://doi.org/10.1038/sj.bjp.0701387
|
[47]
|
Thiemermann, C., Bowes, J., Myint, F.P. and Vane, J.R. (1997) Inhibition of the Activity of Poly(ADP ribose) Synthetase Reduces Ischemia-Reperfusion Injury in the Heart and Skeletal Muscle. Proceedings of the National Academy of Sciences of the United States of America, 94, 679-683. https://doi.org/10.1073/pnas.94.2.679
|
[48]
|
Park, M., Shen, Y.T., Gaussin, V., Heyndrickx, G.R., Bartunek, J., Resuello, R.R., et al. (2009) Apoptosis Predominates in Nonmyocytes in Heart Failure. American Journal of Physiology-Heart and Circulatory Physiology, 297, H785-H791.
https://doi.org/10.1152/ajpheart.00310.2009
|
[49]
|
Jose Corbalan, J., Vatner, D.E. and Vatner, S.F. (2016) Myocardial Apoptosis in Heart Disease: Does the Emperor Have Clothes? Basic Research in Cardiology, 111, Article No. 31. https://doi.org/10.1007/s00395-016-0549-2
|